Despite the similarities with Treg cells in non-lymphoid organs, tumor-resident Treg cells also highly express unique signatures, such as Ccr8, Tnfrsf8, Cxcr3, and Samsn1 (199, 204), which might serve as valuable targets for tumor immunotherapy. The gene discussed is CCR8; the disease is neoplasm.